期刊文献+

膀胱癌患者外周血树突状细胞的体外培养扩增和鉴定 被引量:2

Proliferation and identification of dendritic cells from peripheral blood of patients with bladder cancer in vitro
原文传递
导出
摘要 目的研究膀胱癌患者外周血树突状细胞(DC)的体外培养扩增和鉴定。方法应用Ficoll-Hypaque离心获得界面细胞,贴壁培养2h,获得单个核细胞,体外以重组人粒细胞-巨噬细胞集落刺激因子(rhGM-CSF,50ng/ml)+重组人白细胞介素4(rhlL-4,10ng/ml)+人肿瘤坏死因子-α(hTNF-α,50ng/ml)诱导培养。倒置相差显微镜及扫描电镜下观察DC生长情况;流式细胞仪检测DC表型;MTT法检测DC活化的T细胞对肿瘤细胞BIU87的杀伤率。结果第6天体外培养的DC由贴壁状态变为悬浮毛刺状细胞,第8天为形态不规则的毛刺状,为典型DC形态。流式细胞仪检测表明,成熟DC高水平表达CD_(1a)、CD_(83)、CD_(86)及HLA-DR等。被DC激活的T细胞对膀胱癌细胞株BIU87的杀伤率为(48.8±3.7)%,未经DC激活的T细胞的杀伤率为(25.7±1.5)%,2组比较差异有统计学意义(P<0.01)。结论膀胱癌患者外周血经rhGM-CSF+rhIL-4+hTNF-α体外诱导培养能诱导出DC。 Objective To investigate the proliferation and identification of dendritic cells (DC) derived from peripheral blood of patients with bladder cancer in vitro. Methods The mononuclear cells were prepared from peripheral blood of patients with bladder cancer by Ficoll-Hypaque centrifugation method, and were induced by the recombinant cytokines hGM-CSF ( 50 ng/ml) , hIL-4 ( 10 ng/ml) and hTNF-α ( 50 ng/ ml) for 2 weeks. The growth and morphology of DC were observed through the phase contrast or electron microscope, and their phenotypes were determined by flow cytometry. The capacity of DC to activate T cell-dependent anti-tumor immune responses was tested by MTT method. Results The DC cultured in vitro turned into suspensive growth from adhesive situation on the 6th day, then the number of DC increased continuously and the cells showed the irregular morphologic appearance of DC with veiled edges on the 8th day. Flow cytometry showed that the mature DC expressed high levels of specific markers such as CD1a,CD83, CD86 and HLA-DR. T cells activated by DC showed strong cytotoxicity to bladder cancer cell line BIU87 with a killing rate of (48.8 ± 3.7)% ,while the killing rate of T cells which were not activated by DC was (25.7 ± 1.5) % ;the difference of the rate between them was significant (P 〈 0.01 ). Conclusions The DC can be cultured from peripheral blood of patients with bladder cancer by induction of rhGM-CSF,rhIL-4 and hTNF-α in vitro. This may lay an experimental foundation for further research on DC vaccine.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2006年第7期472-474,共3页 Chinese Journal of Urology
  • 相关文献

参考文献5

  • 1龚非力,主编.免疫学.第2版.北京:高等教育出版社,2004.456-459. 被引量:1
  • 2Almand B,Clark l,Nikitina E,et al.Increased production of immature myeloid cells in cancer patients:A mechanism of immunosuppression in cancer.J Immunol,2001,67:678. 被引量:1
  • 3Troy AJ,Davidson PJT,Atkinson CH,et aI.CDla dendritic cells predominate in transitional cell carcinoma of bladder and kidney but are mimmally activated.J Urol,1999,161:1962-1967. 被引量:1
  • 4冯云,谭会兵,苏华,张宝泉,李若凡,何维.喉癌患者树突状细胞的体外培养与鉴定[J].中国医学科学院学报,2002,24(6):616-619. 被引量:1
  • 5Celluzzi CM,Mayordomo JI,Storkus W,et al.Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.J Exp Med,1996,183:283-287. 被引量:1

二级参考文献9

  • 1Gabriloviceh DI, Chen HL, Girgis KR, et al. Production of vascular endothelial growth factor by human tumors inhibit the functional maturation of dendritic cells. Nat Med, 1996, 2:1096-1103 被引量:1
  • 2Inaba K, Inaba M, Nromani N, et al. Generation of large number of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med, 1992, 176:1693-1702 被引量:1
  • 3Romani N, Gruner S, Brang D, et al. Proliferating dendritic cell progenitors human blood. J Exp Med, 1994, 180:83-93 被引量:1
  • 4Celluzzi CM, Mayordomo JI, Storkus W, et al. Peptidepulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J Exp Med, 1996, 183:283-287 被引量:1
  • 5Steinman, RM. The dendritic cell system and its role in immunogenicity. Annu Rev, 1991, 9:271-296 被引量:1
  • 6Grohamnn U, Bianchi R, Ayroldi E, et al. A tumorassociated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-2 can prevert or revert the anergic state. J Immunol, 1997, 158:3593-3602 被引量:1
  • 7朱学军,曹雪涛,于益芝,陈国友,万涛,马施华,唐华,章卫平.人外周血树突状细胞的体外扩增及鉴定[J].中国肿瘤生物治疗杂志,1997,4(4):302-306. 被引量:91
  • 8朱学军,曹雪涛.树突状细胞与肿瘤免疫治疗研究进展[J].国外医学(免疫学分册),1998,21(6):322-326. 被引量:6
  • 9冯云,张宝泉,谭会兵,苏华,何维.喉癌肿瘤细胞间树突状细胞浸润与局部淋巴转移及癌周淋巴细胞反应的关系[J].中华耳鼻咽喉科杂志,2001,36(4):264-266. 被引量:5

同被引文献20

  • 1孙璇,周四维,庄乾元,管维,叶章群.磁转染MUC1/Y基因入树突状细胞抗膀胱肿瘤的免疫效应研究[J].临床泌尿外科杂志,2007,22(5):379-382. 被引量:4
  • 2Grimm MO, Steinhoff C, Simon X, et al. Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J Urol, 2003, 170: 433-437. 被引量:1
  • 3Sobin LH, Wittekind Ch. TNM classification of malignant tumours. 6th ed. Wiley-Liss: New York, 2002: 199-202. 被引量:1
  • 4冯作化,皇普系穆.分子生物学基本实验技术.北京:人民卫生出版社,2000:6. 被引量:1
  • 5Kurth KH, Bouffioux C, Sylvester R, et al. Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group. Eur Urol, 2000, 37 (Suppl 3 ) : 1-9. 被引量:1
  • 6Herr HW. The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol, 1999, 162: 74-76. 被引量:1
  • 7Divrik RT, Yildirim U, Zodu F, et al. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial. J Urol, 2006, 175 : 1641-1644. 被引量:1
  • 8Brausi M, Collette L, Kurth K. Variability in the recurrence rate at the first follow-up eytoscopy after TUR in stage Ta T1 bladder: a combined analysis of seven EORTC studies. Eur Urol, 2002, 41 : 523-531. 被引量:1
  • 9Pawinski A, Sylvester R, Kurth KH, et al. Acombined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage Ta T1 bladder cancer. European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer. J Urol, 1996, 156:1934-1940. 被引量:1
  • 10Rogers NC, Slack EC, Edwards AD, et al. Syk-dependent cytokine induction by Dectin-I reveals a novel pattern recognition pathway for C type leetins. Immunity, 2005, 22: 507-517. 被引量:1

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部